Meloxidolor

国家: 欧盟

语言: 英文

来源: EMA (European Medicines Agency)

现在购买

资料单张 资料单张 (PIL)
28-01-2022
产品特点 产品特点 (SPC)
28-01-2022
公众评估报告 公众评估报告 (PAR)
13-05-2013

有效成分:

meloxicam

可用日期:

Le Vet Beheer B.V

ATC代码:

QM01AC06

INN(国际名称):

meloxicam

治疗组:

Horses; Dogs; Cattle; Cats; Pigs

治疗领域:

Oxicams

疗效迹象:

DogsAlleviation of inflammation and pain in both acute and chronic musculoskeletal disorders.Reduction of postoperative pain and inflammation following orthopaedic and soft-tissue surgery.CatsReduction of postoperative pain after ovariohysterectomy and minor soft-tissue surgery.CattleFor use in acute respiratory infection with appropriate antibiotic therapy to reduce clinical signs.For use in diarrhoea in combination with oral rehydration therapy to reduce clinical signs in calves of over one week of age and young, non-lactating cattle.For adjunctive therapy in the treatment of acute mastitis, in combination with antibiotic therapy.PigsFor use in noninfectious locomotor disorders to reduce the symptoms of lameness and inflammation.For the relief of postoperative pain associated with minor soft-tissue surgery such as castration.For adjunctive therapy in the treatment of puerperal septicaemia and toxaemia (mastitis-metritis-agalactia syndrome) with appropriate antibiotic therapy.HorsesFor use in the alleviation of inflammation and relief of pain in both acute and chronic musculoskeletal disorders.For the relief of pain associated with equine colic.

產品總結:

Revision: 9

授权状态:

Authorised

授权日期:

2013-04-22

资料单张

                                17
PARTICULARS TO APPEAR ON THE OUTER PACKAGE AND THE IMMEDIATE
PACKAGE
CARTON FOR THE 10 ML, 20 ML AND 100 ML
LABEL FOR 100 ML
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Meloxidolor 5 mg/ml solution for injection for dogs, cats, cattle and
pigs
meloxicam
2.
STATEMENT OF ACTIVE SUBSTANCES
Meloxicam 5 mg/ml
3.
PHARMACEUTICAL FORM
Solution for injection
4.
PACKAGE SIZE
10 ml
20 ml
100 ml
5.
TARGET SPECIES
Dogs, cats, cattle (calves) and pigs
6.
INDICATION(S)
7.
METHOD AND ROUTE(S) OF ADMINISTRATION
Dogs, Cattle: Single subcutaneous or intravenous injection
Cats: Single subcutaneous injection
Pigs: Single intramuscular injection
Read the package leaflet before use
8.
WITHDRAWAL PERIOD(S)
Withdrawal period:
CATTLE:
Meat and offal: 15 days
PIGS:
Meat and offal: 5 days
18
9.
SPECIAL WARNING(S), IF NECESSARY
Read the package leaflet before use.
10.
EXPIRY DATE
EXP (month/year)
Once broached, use by….
11.
SPECIAL STORAGE CONDITIONS
Read the package leaflet before use.
12.
SPECIAL PRECAUTIONS FOR THE DISPOSAL OF UNUSED PRODUCTS OR
WASTE MATERIALS, IF ANY
Disposal: read package leaflet.
13.
THE WORDS “FOR ANIMAL TREATMENT ONLY” AND CONDITIONS OR
RESTRICTIONS REGARDING SUPPLY AND USE, IF APPLICABLE
For animal treatment only. To be supplied only on veterinary
prescription.
14.
THE WORDS “KEEP OUT OF THE SIGHT AND REACH OF CHILDREN”
Keep out of the sight and reach of children.
15.
NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER
Le Vet Beheer B.V.
Wilgenweg 7
3421 TV Oudewater
The Netherlands
16.
MARKETING AUTHORISATION NUMBER(S)
EU/2/13/148/001
EU/2/13/148/002
EU/2/13/148/003
EU/2/13/148/008
EU/2/13/148/009
17.
MANUFACTURER’S BATCH NUMBER
Batch {number}
19
MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS
LABEL FOR 10 ML AND 20 ML
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Meloxidolor 5 mg/ml solution for injection for dogs, cats, cattle and
pigs
meloxicam
2.
QUANTITY OF THE ACTIVE SUBSTANCE(S)
Meloxicam 5 mg/ml
3.
CONTENTS BY WEIGHT, BY VOLUME OR BY NUMBER OF DOSES
10 ml
20 ml
4.
ROUTE(S) 
                                
                                阅读完整的文件
                                
                            

产品特点

                                1
ANNEX I
SUMMARY OF PRODUCT CHARACTERISTICS
2
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Meloxidolor 5 mg/ml solution for injection for dogs, cats, cattle and
pigs
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
One ml contains:
ACTIVE SUBSTANCE:
Meloxicam 5 mg
EXCIPIENT:
Ethanol 150 mg
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Solution for injection.
Clear yellow solution.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dogs, cats, cattle (calves) and pigs
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
DOGS:
Alleviation of inflammation and pain in both acute and chronic
musculo-skeletal disorders. Reduction
of post-operative pain and inflammation following orthopaedic and soft
tissue surgery.
CATS:
Reduction of post-operative pain after ovariohysterectomy and minor
soft tissue surgery.
CATTLE:
For use in acute respiratory infection with appropriate antibiotic
therapy to reduce clinical signs in
cattle.
For use in diarrhoea in combination with oral re-hydration therapy to
reduce clinical signs in calves of
over one week of age.
For the relief of post-operative pain following dehorning in calves.
PIGS:
For use in non-infectious locomotor disorders to reduce the symptoms
of lameness and inflammation.
For the relief of post-operative pain associated with minor soft
tissue surgery such as castration.
4.3
CONTRAINDICATIONS
Do not use in cases of hypersensitivity to the active substance or to
any of the excipients.
Do not use in dogs and cats suffering from gastrointestinal disorders
such as irritation and
haemorrhage, impaired hepatic, cardiac or renal function and
haemorrhagic disorders.
Do not use in dogs and cats less than 6 weeks of age nor in cats of
less than 2 kg.
3
Do not use in cattle and pigs suffering from impaired hepatic, cardiac
or renal function and
haemorrhagic disorders, or where there is evidence of ulcerogenic
gastrointestinal lesions.
For the treatment of diarrhoea in cattle, do not use in animals of
less than one week of age.
Do not use in pigs less than 2 days old.
                                
                                阅读完整的文件
                                
                            

其他语言的文件

资料单张 资料单张 保加利亚文 28-01-2022
产品特点 产品特点 保加利亚文 28-01-2022
公众评估报告 公众评估报告 保加利亚文 13-05-2013
资料单张 资料单张 西班牙文 28-01-2022
产品特点 产品特点 西班牙文 28-01-2022
公众评估报告 公众评估报告 西班牙文 13-05-2013
资料单张 资料单张 捷克文 28-01-2022
产品特点 产品特点 捷克文 28-01-2022
公众评估报告 公众评估报告 捷克文 13-05-2013
资料单张 资料单张 丹麦文 28-01-2022
产品特点 产品特点 丹麦文 28-01-2022
公众评估报告 公众评估报告 丹麦文 13-05-2013
资料单张 资料单张 德文 28-01-2022
产品特点 产品特点 德文 28-01-2022
公众评估报告 公众评估报告 德文 13-05-2013
资料单张 资料单张 爱沙尼亚文 28-01-2022
产品特点 产品特点 爱沙尼亚文 28-01-2022
公众评估报告 公众评估报告 爱沙尼亚文 13-05-2013
资料单张 资料单张 希腊文 28-01-2022
产品特点 产品特点 希腊文 28-01-2022
公众评估报告 公众评估报告 希腊文 13-05-2013
资料单张 资料单张 法文 28-01-2022
产品特点 产品特点 法文 28-01-2022
公众评估报告 公众评估报告 法文 13-05-2013
资料单张 资料单张 意大利文 28-01-2022
产品特点 产品特点 意大利文 28-01-2022
公众评估报告 公众评估报告 意大利文 13-05-2013
资料单张 资料单张 拉脱维亚文 28-01-2022
产品特点 产品特点 拉脱维亚文 28-01-2022
公众评估报告 公众评估报告 拉脱维亚文 13-05-2013
资料单张 资料单张 立陶宛文 28-01-2022
产品特点 产品特点 立陶宛文 28-01-2022
公众评估报告 公众评估报告 立陶宛文 13-05-2013
资料单张 资料单张 匈牙利文 28-01-2022
产品特点 产品特点 匈牙利文 28-01-2022
公众评估报告 公众评估报告 匈牙利文 13-05-2013
资料单张 资料单张 马耳他文 28-01-2022
产品特点 产品特点 马耳他文 28-01-2022
公众评估报告 公众评估报告 马耳他文 13-05-2013
资料单张 资料单张 荷兰文 28-01-2022
产品特点 产品特点 荷兰文 28-01-2022
公众评估报告 公众评估报告 荷兰文 13-05-2013
资料单张 资料单张 波兰文 28-01-2022
产品特点 产品特点 波兰文 28-01-2022
公众评估报告 公众评估报告 波兰文 13-05-2013
资料单张 资料单张 葡萄牙文 28-01-2022
产品特点 产品特点 葡萄牙文 28-01-2022
公众评估报告 公众评估报告 葡萄牙文 13-05-2013
资料单张 资料单张 罗马尼亚文 28-01-2022
产品特点 产品特点 罗马尼亚文 28-01-2022
公众评估报告 公众评估报告 罗马尼亚文 13-05-2013
资料单张 资料单张 斯洛伐克文 28-01-2022
产品特点 产品特点 斯洛伐克文 28-01-2022
公众评估报告 公众评估报告 斯洛伐克文 13-05-2013
资料单张 资料单张 斯洛文尼亚文 28-01-2022
产品特点 产品特点 斯洛文尼亚文 28-01-2022
公众评估报告 公众评估报告 斯洛文尼亚文 13-05-2013
资料单张 资料单张 芬兰文 28-01-2022
产品特点 产品特点 芬兰文 28-01-2022
公众评估报告 公众评估报告 芬兰文 13-05-2013
资料单张 资料单张 瑞典文 28-01-2022
产品特点 产品特点 瑞典文 28-01-2022
公众评估报告 公众评估报告 瑞典文 13-05-2013
资料单张 资料单张 挪威文 28-01-2022
产品特点 产品特点 挪威文 28-01-2022
资料单张 资料单张 冰岛文 28-01-2022
产品特点 产品特点 冰岛文 28-01-2022
资料单张 资料单张 克罗地亚文 28-01-2022
产品特点 产品特点 克罗地亚文 28-01-2022

搜索与此产品相关的警报

查看文件历史